Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy

Paraskevi Diamanti, Charlotte V. Cox, Benjamin C. Ede, Robert A. Uger, John P. Moppett, Allison Blair

Blood Adv (2021) 5 (18): 3694–3708.

https://doi.org/10.1182/bloodadvances.2020003534

Published: 2021

Includes: Supplemental data

Journal Articles

Enhanced self-renewal of human long-term hematopoietic stem cells by a sulfamoyl benzoate derivative targeting p18 INK4C

Blood Adv (2021) 5 (17): 3362–3372.

https://doi.org/10.1182/bloodadvances.2020004054

Published: 2021

Includes: Supplemental data

Journal Articles

Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma

Hilma J. van der Horst, Anne T. Gelderloos, Martine E. D. Chamuleau, Esther C. W. Breij, Sonja Zweegman, Inger S. Nijhof, Marije B. Overdijk, Tuna Mutis

Blood Adv (2021) 5 (8): 2165–2172.

https://doi.org/10.1182/bloodadvances.2020003731

Published: 2021

Includes: Supplemental data

Journal Articles

Functional characterization of PD1 + TIM3 + tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade

Mikaël Roussel, Kieu-Suong Le, Clémence Granier, Francisco Llamas Gutierrez, Etienne Foucher, Simon Le Gallou, Céline Pangault, Luc Xerri, Vincent Launay, Thierry Lamy, Eric Tartour, Daniel Olive, Thierry Fest

Blood Adv (2021) 5 (7): 1816–1829.

https://doi.org/10.1182/bloodadvances.2020003080

Published: 2021

Includes: Supplemental data

Journal Articles

Proteomic and bioinformatic profiling of neutrophils in CLL reveals functional defects that predispose to bacterial infections

Blood Adv (2021) 5 (5): 1259–1272.

https://doi.org/10.1182/bloodadvances.2020002949

Published: 2021

Includes: Supplemental data

Journal Articles

Molecular coevolution of coagulation factor VIII and von Willebrand factor

Philip M. Zakas, Christopher W. Coyle, Anja Brehm, Marion Bayer, Barbara Solecka-Witulska, Caelan E. Radford, Christine Brown, Kate Nesbitt, Courtney Dwyer, Christoph Kannicht, H. Trent Spencer, Eric A. Gaucher, Christopher B. Doering, David Lillicrap

Blood Adv (2021) 5 (3): 812–822.

https://doi.org/10.1182/bloodadvances.2020002971

Published: 2021

Includes: Supplemental data

Journal Articles

Concizumab: a novel anti-TFPI therapeutic for hemophilia

Amy D. Shapiro

Blood Adv (2021) 5 (1): 279.

https://doi.org/10.1182/bloodadvances.2019001140

Published: 2021

Includes: Supplemental data

Journal Articles

AMG 701 induces cytotoxicity of multiple myeloma cells and depletes plasma cells in cynomolgus monkeys

Rebecca L. Goldstein, Ana Goyos, Chi-Ming Li, Petra Deegen, Pamela Bogner, Alexander Sternjak, Oliver Thomas, Matthias Klinger, Joachim Wahl, Matthias Friedrich, Benno Rattel, Edwin Lamas, Xiaoshan Min, Athena Sudom, Mozhgan Farshbaf, Angela Coxon, Mercedesz Balazs, Tara Arvedson

Blood Adv (2020) 4 (17): 4180–4194.

https://doi.org/10.1182/bloodadvances.2020002565

Published: 2020

Includes: Supplemental data

Journal Articles

Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734

Filippo Spriano, Eugenio Gaudio, Luciano Cascione, Chiara Tarantelli, Federica Melle, Giovanna Motta, Valdemar Priebe, Andrea Rinaldi, Gaetanina Golino, Afua Adjeiwaa Mensah, Luca Aresu, Emanuele Zucca, Stefano Pileri, Michael Witcher, Bill Brown, Claes Wahlestedt, Francis Giles, Anastasios Stathis, Francesco Bertoni

Blood Adv (2020) 4 (17): 4124–4135.

https://doi.org/10.1182/bloodadvances.2020001879

Published: 2020

Includes: Supplemental data

Journal Articles

Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D′D3 and D4 domains

Monica Sacco, Stefano Lancellotti, Mattia Ferrarese, Francesco Bernardi, Mirko Pinotti, Maira Tardugno, Erica De Candia, Leonardo Di Gennaro, Maria Basso, Betti Giusti, Massimiliano Papi, Giordano Perini, Giancarlo Castaman, Raimondo De Cristofaro

Blood Adv (2020) 4 (14): 3405–3415.

https://doi.org/10.1182/bloodadvances.2020002334

Published: 2020

Includes: Supplemental data

Journal Articles

Apohemoglobin-haptoglobin complexes attenuate the hypertensive response to low-molecular-weight polymerized hemoglobin

Donald A. Belcher, Carlos Munoz, Ivan S. Pires, Alexander T. Williams, Pedro Cabrales, Andre F. Palmer

Blood Adv (2020) 4 (12): 2739–2750.

https://doi.org/10.1182/bloodadvances.2020002045

Published: 2020

Journal Articles

Myeloma cells induce the accumulation of activated CD94 low NK cells by cell-to-cell contacts involving CD56 molecules

Chiara Barberi, Claudia De Pasquale, Alessandro Allegra, Giacomo Sidoti Migliore, Daniela Oliveri, Fabrizio Loiacono, Vanessa Innao, Caterina Musolino, Daniela Pende, Claudia Cantoni, Paolo Carrega, Maria Cristina Mingari, Stefania Campana, Guido Ferlazzo

Blood Adv (2020) 4 (10): 2297–2307.

https://doi.org/10.1182/bloodadvances.2019000953

Published: 2020

Includes: Supplemental data

Journal Articles

Laboratory monitoring of hemophilia A treatments: new challenges

Peter J. Lenting

Blood Adv (2020) 4 (9): 2111–2118.

https://doi.org/10.1182/bloodadvances.2019000849

Published: 2020

Journal Articles

IκB kinase 2 is not essential for platelet activation

Manuel Salzmann, Sonja Bleichert, Bernhard Moser, Marion Mussbacher, Mildred Haase, Bastian Hoesel, Waltraud C. Schrottmaier, Julia B. Kral-Pointner, Makoto Itakura, Katy Schmidt, Alice Assinger, Johannes A. Schmid

Blood Adv (2020) 4 (4): 638–643.

https://doi.org/10.1182/bloodadvances.2019001044

Published: 2020

Includes: Supplemental data

Journal Articles

Venous thrombosis at altitude presents with distinct biochemical profiles: a comparative study from the Himalayas to the plains

Amit Prabhakar, Tathagata Chatterjee, Nitin Bajaj, Tarun Tyagi, Anita Sahu, Neha Gupta, Babita Kumari, Velu Nair, Bhuvnesh Kumar, Mohammad Zahid Ashraf

Blood Adv (2019) 3 (22): 3713–3723.

https://doi.org/10.1182/bloodadvances.2018024554

Published: 2019

Includes: Supplemental data

Journal Articles

CAR T-cell therapy: is it prime time in myeloma?

Surbhi Sidana, Nina Shah

Blood Adv (2019) 3 (21): 3473–3480.

https://doi.org/10.1182/bloodadvances.2019000370

Published: 2019

Journal Articles

Neutrophils acquire antigen-presenting cell features after phagocytosis of IgG-opsonized erythrocytes

Sanne M. Meinderts, Gabriella Baker, Stan van Wijk, Boukje M. Beuger, Judy Geissler, Machiel H. Jansen, Anno Saris, Anja ten Brinke, Taco W. Kuijpers, Timo K. van den Berg, Robin van Bruggen

Blood Adv (2019) 3 (11): 1761–1773.

https://doi.org/10.1182/bloodadvances.2018028753

Published: 2019

Includes: Supplemental data

Journal Articles

The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells

Xianjiang Lan, Eugene Khandros, Peng Huang, Scott A. Peslak, Saurabh K. Bhardwaj, Jeremy D. Grevet, Osheiza Abdulmalik, Hongxin Wang, Cheryl A. Keller, Belinda Giardine, Josue Baeza, Emily R. Duffner, Osama El Demerdash, Xiaoli S. Wu, Christopher R. Vakoc, Benjamin A. Garcia, Ross C. Hardison, Junwei Shi, Gerd A. Blobel

Blood Adv (2019) 3 (10): 1586–1597.

https://doi.org/10.1182/bloodadvances.2019032318

Published: 2019

Includes: Supplemental data

Journal Articles

Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products

Wojciech Jankowski, Yara Park, Joseph McGill, Eugene Maraskovsky, Marco Hofmann, Vincent P. Diego, Bernadette W. Luu, Tom E. Howard, Roberta Kellerman, Nigel S. Key, Zuben E. Sauna

Blood Adv (2019) 3 (9): 1429–1440.

https://doi.org/10.1182/bloodadvances.2018030452

Published: 2019

Includes: Supplemental data

Journal Articles

Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL

Martin Felices, Behiye Kodal, Peter Hinderlie, Michael F. Kaminski, Sarah Cooley, Daniel J. Weisdorf, Daniel A. Vallera, Jeffrey S. Miller, Veronika Bachanova

Blood Adv (2019) 3 (6): 897–907.

https://doi.org/10.1182/bloodadvances.2018029371

Published: 2019

Includes: Supplemental data

NARROW

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy

Enhanced self-renewal of human long-term hematopoietic stem cells by a sulfamoyl benzoate derivative targeting p18 INK4C

Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma

Functional characterization of PD1 + TIM3 + tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade

Proteomic and bioinformatic profiling of neutrophils in CLL reveals functional defects that predispose to bacterial infections

Molecular coevolution of coagulation factor VIII and von Willebrand factor

Concizumab: a novel anti-TFPI therapeutic for hemophilia

AMG 701 induces cytotoxicity of multiple myeloma cells and depletes plasma cells in cynomolgus monkeys

Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734

Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D′D3 and D4 domains

Apohemoglobin-haptoglobin complexes attenuate the hypertensive response to low-molecular-weight polymerized hemoglobin

Myeloma cells induce the accumulation of activated CD94 low NK cells by cell-to-cell contacts involving CD56 molecules

Laboratory monitoring of hemophilia A treatments: new challenges

IκB kinase 2 is not essential for platelet activation

Venous thrombosis at altitude presents with distinct biochemical profiles: a comparative study from the Himalayas to the plains

CAR T-cell therapy: is it prime time in myeloma?

Neutrophils acquire antigen-presenting cell features after phagocytosis of IgG-opsonized erythrocytes

The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells

Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products

Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only